UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 12,
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Dare Bioscience Charts.
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Dare Bioscience Charts.

Dare Bioscience, Inc. News

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
Thursday 2 May 2024 (2 days ago) • GlobeNewswire Inc.
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
Tuesday 30 April 2024 (5 days ago) • GlobeNewswire Inc.
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Tuesday 23 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.
US Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices Rise
Thursday 28 March 2024 (1 month ago) • IH Market News
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
Thursday 1 February 2024 (3 months ago) • GlobeNewswire Inc.
Form 3 - Initial statement of beneficial ownership of securities
Tuesday 30 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)
Daré Bioscience Announces Executive Team and Board of Directors Changes
Saturday 27 January 2024 (3 months ago) • GlobeNewswire Inc.

More Dare Bioscience, Inc. News Articles